Taiwan Semiconductor is in a unique place in the AI arms race. Companies like AMD and Nvidia don't build any computing units; ...

Eli Lilly is currently leading the GLP-1 market, but Amylyx is seeing strong results from its GLP-1 drug candidate.

Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in.

Target fell out of favor with consumers, but it has started to get back on track, and investors have taken notice.

D-Wave is moving from experiments to live enterprise workloads, but the valuation leaves little room for error. See what ...

Friday's double-digit pop celebrated a quarter in which three of four brands shrank or stalled. The one that didn't is ...

Spousal benefits max out at 50% of the amount your spouse is entitled to at full retirement age. If you delay a spousal ...

SpaceX is no longer just a futuristic story. It's already a large and rapidly growing business. SpaceX generated $7.8 billion of revenue in the second quarter, up 92% from a year earlier. Adjusted ...

The global shortage of AI chips and components is giving Nvidia an unprecedented ability to dictate prices, which is also a ...

In the earliest stages of the AI boom, this growth resulted in stock price gains, with the shares climbing 800% over the past ...

Boeing delivered 171 commercial aircraft in the second quarter -- a 14% increase from the 150 a year earlier. And revenue ...

Micron is looking beyond today's AI boom. Its latest investments reveal where it sees future demand emerging, but one major ...